Jump to content
Wikipedia The Free Encyclopedia

Hormone therapy

From Wikipedia, the free encyclopedia
(Redirected from Hormonal modulators)
Use of hormones in medical treatment
This article needs additional citations for verification . Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Hormone therapy" – news · newspapers · books · scholar · JSTOR
(December 2009) (Learn how and when to remove this message)

Hormone therapy or hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also be referred to as hormonal therapy or antihormone therapy. The most general classes of hormone therapy are oncologic hormone therapy, hormone replacement therapy (for menopause), androgen replacement therapy (ART), oral contraceptive pills, and Gender-affirming hormone therapy.

Types

[edit ]

See also

[edit ]

References

[edit ]
  1. ^ Shuster, Lynne T.; Rhodes, Deborah J.; Gostout, Bobbie S.; Grossardt, Brandon R.; Rocca, Walter A. (2010). "Premature menopause or early menopause: Long-term health consequences". Maturitas . 65 (2): 161–166. doi:10.1016/j.maturitas.200908003. ISSN 0378-5122. PMC 2815011 . PMID 19733988.
  2. ^ Kang, DY; Li, HJ (January 2015). "The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis". Medicine. 94 (3): e410. doi:10.1097/MD.0000000000000410. PMC 4602637 . PMID 25621688.
  3. ^ Giwercman, A; Lundberg Giwercman, Y (2015). "Hypogonadism in young men treated for cancer". Hormones. 14 (4): 590–7. doi:10.14310/horm.2002.1650 . PMID 26859600. Open access icon
  4. ^ Staff (3 March 2015). "FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack And Stroke". FDA . Retrieved 5 March 2015.. NEJM Perspective piece: Nguyen, CP; et al. (20 August 2015). "Testosterone and "Age-Related Hypogonadism"--FDA Concerns". The New England Journal of Medicine. 373 (8): 689–91. doi:10.1056/nejmp1506632. PMC 8905399 . PMID 26287846.. Popular summary: Tavernise, Sabrina (March 3, 2015). "Drugs Using Testosterone Will Label Heart Risks". New York Times . Retrieved March 19, 2015.
  5. ^ "What is Bioidentical Hormone Replacement Therapy?". WebMD. Retrieved 2024年07月26日.
  6. ^ Oropeza, Yosbel (2023年10月19日). "Hormone Pellet Therapy: What It Is, Why It Works, and How a Compounding Pharmacy Can Help". Wells Pharmacy Network. Retrieved 2024年07月26日.
Androgens
(incl. AAS Tooltip anabolic–androgenic steroid)
AR Tooltip Androgen receptor agonists
Progonadotropins
Antiandrogens
AR Tooltip Androgen receptor antagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
Estrogens
ER Tooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ER Tooltip Estrogen receptor antagonists
(incl. SERMs Tooltip selective estrogen receptor modulators/SERDs Tooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
Progestogens
(and progestins)
PR Tooltip Progesterone receptor agonists
Antiprogestogens
SPRMs Tooltip Selective progesterone receptor modulators
PR Tooltip Progesterone receptor antagonists

AltStyle によって変換されたページ (->オリジナル) /